European Journal of Cancer
Volume 42, Issue 15 , Pages 2472-2479 , October 2006

To predict progression-free survival and overall survival in metastatic renal cancer treated with sorafenib: Pilot study using dynamic contrast-enhanced Doppler ultrasound

  • Michele Lamuraglia

      Affiliations

    • Department of Medical Imaging, Institut Gustave Roussy, 39 rue Camille Desmoulins, 94805 Villejuif, France
    • Section of Internal Medicine, Department of Internal Medicine and Public Medicine, University of Bari, Piazza Giulio Cesare 11, 70124 Bari, Italy
  • ,
  • Bernard Escudier

      Affiliations

    • Department of Medicine, Institut Gustave Roussy, 39 rue Camille Desmoulins, 94805 Villejuif, France
  • ,
  • Linda Chami

      Affiliations

    • Department of Medical Imaging, Institut Gustave Roussy, 39 rue Camille Desmoulins, 94805 Villejuif, France
  • ,
  • Brian Schwartz

      Affiliations

    • Bayer Pharmaceuticals Corporation, West Haven CT 06516, USA
  • ,
  • Jérome Leclère

      Affiliations

    • Department of Medical Imaging, Institut Gustave Roussy, 39 rue Camille Desmoulins, 94805 Villejuif, France
  • ,
  • Alain Roche

      Affiliations

    • Department of Medical Imaging, Institut Gustave Roussy, 39 rue Camille Desmoulins, 94805 Villejuif, France
  • ,
  • Nathalie Lassau

      Affiliations

    • Department of Medical Imaging, Institut Gustave Roussy, 39 rue Camille Desmoulins, 94805 Villejuif, France
    • Corresponding Author InformationCorresponding author: Tel.: +33 1 42 11 60 14; fax: +33 1 42 11 60 29.

Received 15 February 2006 ,Revised 18 April 2006 ,Accepted 20 April 2006.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 This work was presented at the ASCO and ECCO meetings in 2005.

PII: S0959-8049(06)00607-1

doi: 10.1016/j.ejca.2006.04.023

European Journal of Cancer
Volume 42, Issue 15 , Pages 2472-2479 , October 2006